Pharmaceutical companies know they need to digitally innovate. According to a GlobalData survey, 40% of pharmaceutical industry professionals in Europe and North America believe that the COVID-19 pandemic accelerated digital transformation by more than five years.
The industry is duly responding to the transformation requirement and is expected to invest $4.5 billion on digital evolution by 2030.
At the same time, pharma companies face a host of regulatory challenges that demand sophisticated data management and security capabilities.
Check out the rest of this feature here
